EXTEND (International): Extending the Time for Thrombolysis in Emergency Neurological Deficits (International)

NCT01580839 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

45

Enrollment

OTHER

Sponsor class

Conditions

Stroke

Interventions

DRUG: Tissue Plasminogen Activator (Alteplase)
DRUG: Placebo

Sponsor

Neuroscience Trials Australia

Collaborators

[object Object]